Estimating Microvascular Invasion in Patients with Resectable Multinodular Hepatocellular Carcinoma by Using Preoperative Contrast-Enhanced MRI: Establishment and Validation of a Risk Score

References

• Kudo M, Izumi N, Ichida T, et al. Report of the 19th follow-up survey of primary liver cancer in Japan. Hepatol Res. 2016;5(46):372–390. doi:10.1111/hepr.12697
   Google Scholar
• Cao L, Cheng H, Jiang Q, Li H, Wu Z. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Aging. 2020;5(12):4573–4591.
   Google Scholar
• Wu Z, Cheng H, Liu J, et al. The oncogenic and diagnostic potential of stanniocalcin 2 in hepatocellular carcinoma. J Hepatocell Carcinoma. 2022;Volume 9:141–155. doi:10.2147/JHC.S351882
   Web of Science ®Google Scholar
• Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;15(380):1450–1462. doi:10.1056/NEJMra1713263
   Google Scholar
• Hyun MH, Lee YS, Kim JH, et al. Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: a meta-analysis of high-quality studies. Hepatology. 2018;3(68):977–993. doi:10.1002/hep.29883
   Google Scholar
• Yin L, Li H, Li AJ, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT. J Hepatol. 2014;1(61):82–88. doi:10.1016/j.jhep.2014.03.012
   Google Scholar
• Zaydfudim VM, Vachharajani N, Klintmalm GB, et al. Liver resection and transplantation for patients with hepatocellular carcinoma beyond Milan criteria. Ann Surg. 2016;4(264):650–658. doi:10.1097/SLA.0000000000001866
   Google Scholar
• Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg. 2014;2(260):329–340. doi:10.1097/SLA.0000000000000236
   Google Scholar
• Hong SB, Choi SH, Kim SY, et al. MRI Features for predicting microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer. 2021;2(10):94–106. doi:10.1159/000513704
   Google Scholar
• Rodríguez-Perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;1(20):325–339. doi:10.1245/s10434-012-2513-1
   Google Scholar
• Zhang X, Li J, Shen F, Lau WY. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. J Gastroen Hepatol. 2018;2(33):347–354. doi:10.1111/jgh.13843
   Google Scholar
• Cong W, Bu H, Chen J, et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroentero. 2016;42(22):9279. doi:10.3748/wjg.v22.i42.9279
   Google Scholar
• Li M, Yin Z, Hu B, et al. MR elastography-based shear strain mapping for assessment of microvascular invasion in hepatocellular carcinoma. Eur Radiol. 2022;7(32):5024–5032. doi:10.1007/s00330-022-08578-w
   Google Scholar
• Lee S, Kim SH, Lee JE, Sinn DH, Park CK. Preoperative gadoxetic acid–enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol. 2017;3(67):526–534. doi:10.1016/j.jhep.2017.04.024
   Google Scholar
• Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? Am J Roentgenol. 2011;5(196):1083. doi:10.2214/AJR.10.4720
   Google Scholar
• Zhao WC, Fan LF, Yang N, Zhang HB, Chen BD, Yang GS. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma. Eur J Surg Oncol. 2013;8(39):858–864. doi:10.1016/j.ejso.2013.04.003
   Google Scholar
• Chen J, Zhou J, Kuang S, et al. Liver imaging reporting and data system category 5: MRI predictors of microvascular invasion and recurrence after hepatectomy for hepatocellular carcinoma. AJR Am J Roentgenol. 2019;4(213):821–830. doi:10.2214/AJR.19.21168
   Google Scholar
• Zhang K, Xie SS, Li WC, Ye ZX, Shen ZW, Shen W. Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators. Eur Radiol. 2022;6(32):4186–4197. doi:10.1007/s00330-021-08502-8
   Google Scholar
• Dong S, Wang W, Chen X, et al. Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI. Eur Radiol. 2022;6(32):4198–4209. doi:10.1007/s00330-021-08495-4
   Google Scholar
• Chong H, Yang L, Sheng R, et al. Multi-scale and multi-parametric radiomics of gadoxetate disodium–enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm. Eur Radiol. 2021;7(31):4824–4838. doi:10.1007/s00330-020-07601-2
   Google Scholar
• Goldberg D, Mantero A, Newcomb C, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score. J Hepatol. 2021;6(74):1398–1406. doi:10.1016/j.jhep.2020.12.021
   Google Scholar
• Wang S, Tian S, Li Y, et al. Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion. Ebiomedicine. 2020;58:102924. doi:10.1016/j.ebiom.2020.102924
   PubMed Web of Science ®Google Scholar
• Kim AY, Sinn DH, Jeong WK, et al. Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma. J Hepatol. 2018;6(68):1144–1152. doi:10.1016/j.jhep.2018.01.024
   Google Scholar
• Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;3(137):850–855. doi:10.1053/j.gastro.2009.06.003
   Google Scholar
• Banerjee S, Wang DS, Kim HJ, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology. 2015;3(62):792–800. doi:10.1002/hep.27877
   Google Scholar
• Yang L, Gu D, Wei J, et al. A radiomics nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Liver Cancer. 2019;5(8):373–386. doi:10.1159/000494099
   Google Scholar
• Lu L, Hsu C, Hsu C, Cheng A. Tumor heterogeneity in hepatocellular carcinoma: facing the challenges. Liver Cancer. 2016;2(5):128–138. doi:10.1159/000367754
   Google Scholar
• Gao Q, Wang X, Zhou J, Fan J. Multiple carcinogenesis contributes to the heterogeneity of HCC. Nat Rev Gastro Hepat. 2015;1(12):13. doi:10.1038/nrgastro.2014.6-c1
   Google Scholar
• Xu LX, He MH, Dai ZH, et al. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Ann Oncol. 2019;6(30):990–997. doi:10.1093/annonc/mdz103
   Google Scholar
• Song D, Wang Y, Wang W, et al. Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters. J Cancer Res Clin. 2021;12(147):3757–3767. doi:10.1007/s00432-021-03617-3
   Google Scholar
• Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology. 2014;3(272):635–654. doi:10.1148/radiol.14132361
   Google Scholar
• Mchugh PP, Gilbert J, Vera S, Koch A, Ranjan D, Gedaly R. Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. HPB. 2010;1(12):56–61. doi:10.1111/j.1477-2574.2009.00128.x
   Google Scholar
• Ajr AJOR. Liver Reporting & Data System (LI-RADS). Available from: www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS. Accessed April 29, 2022.
   Google Scholar
• Yang S, Luo Y, Chen M, et al. A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy. Hpb. 2017;10(19):835–842. doi:10.1016/j.hpb.2017.06.002
   Google Scholar